Details of the Drug
General Information of Drug (ID: DMTCEFV)
Drug Name |
Glycinamid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Glycinamide; 2-Aminoacetamide; 598-41-4; Glycine amide; Acetamide, 2-amino-; GLYCINAMID; AMINOMETHYLAMIDE; 2-Amino-Acetamide; CHEBI:42843; BEBCJVAWIBVWNZ-UHFFFAOYSA-N; Glycinamide HCl; AI3-60342; aminoacetamide; glycineamide; glycinamidehcl; glycine-amide; glycine imine; Glycinimidic acid; alpha-aminoacetamide; EINECS 209-932-4; GlyNH2; 2-Aminoacetamide #; Gly-NH2; Glycineamide, G-NH2; AC1L2AXY; H2NCH2CONH2; Glycine amide hydrobromide; AC1Q53MT; CHEMBL86954; 598-41-4 (Parent); DTXSID1060508; 1668-10-6 (hydrochloride); CTK1H1328; CTK1D7741
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 74.08 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||